The review identified and categorised the legal issues that need to be addressed as the business continues to develop.
ABACUS carried out comprehensive legal due diligence on Hempfarm covering the period 2022–2025, including a review of the corporate and operational aspects of its business.
ABACUS advised on an investment transaction structured as a convertible loan, which provided for the transfer of a 10% interest in the company’s charter capital upon conversion.
ABACUS advised a foreign investor on the acquisition of a 49% interest in the charter capital of an Uzbek property development company.
ABACUS advised on a cross-border investment transaction in which a participatory interest (shares) in a Russian company was contributed to the charter capital of an Uzbek company.
There is no charge for an initial review of your enquiry. We reply within 24 hours on working days.